Viewing Study NCT01293435



Ignite Creation Date: 2024-05-05 @ 11:16 PM
Last Modification Date: 2024-10-26 @ 10:31 AM
Study NCT ID: NCT01293435
Status: COMPLETED
Last Update Posted: 2012-09-07
First Post: 2011-02-06

Brief Title: Study Evaluating Management of Patients With Community-Acquired Pneumonia CAP or Complicated Skin Infections
Sponsor: AstraZeneca
Organization: AstraZeneca

Study Overview

Official Title: Observational Study to Assess Clinical Management Patterns in Patients With Hospitalised Community-Acquired Pneumonia CAP or Complicated Skin and Skin Structure Infections cSSSI
Status: COMPLETED
Status Verified Date: 2012-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: REACH
Brief Summary: This study will collect real-life data from patients with community acquired pneumonia CAP OR complicated skin and skin structure infections cSSSI to assess the burden of the disease review the treatment pathways evaluate how health resources are used and identify any areas of unmet medical needs The aim of the study is to compare how patients who are admitted to hospital with CAP or cSSSI are managed across Europe This will be done by collecting data to understand the patient and disease characteristics current practice of treatment and outcomes for the patient Overall 4000 patients will be recruited from 10 European countries
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None